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ABSTRACT 
Epidermal keratinocytes migrate through the epidermis up to the granular layer where, upon terminal 
differentiation they progressively loose organelles and convert into anucleate cells or corneocytes. Our 
report explores the role of autophagy in ensuring epidermal function providing the first comprehensive 
profile of autophagy marker expression in developing epidermis. We show that autophagy is constitutively 
active in epidermal granular layer where by electron microscopy we identified double membrane-
autophagosomes. We demonstrate that differentiating keratinocytes undergo a selective form of 
nucleophagy characterized by accumulation of LC3/LAMP2/p62 positive autolysosomes. These 
perinuclear vesicles displayed positivity for histone interacting protein HP1α and localize in proximity with 
Lamin A and B1 accumulation, while in newborn mice and adult human skin we report LC3 puncta 
coincident with misshaped nuclei within the granular layer. This process relies on autophagy integrity as 
confirmed by lack of nucleophagy in differentiating keratinocytes depleted from WIPI1 or ULK1. Final 
validation into a skin disease model showed that impaired autophagy contributes to the pathogenesis of 
psoriasis. Lack of LC3 expression in psoriatic skin lesions correlates with parakeratosis and deregulated 
expression or location of most of the autophagic markers. Our findings may have implications and improve 
treatment options for patients with epidermal barrier defects. 
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INTRODUCTION 
The epidermis is a multilayered structure continuously renewed by keratinocytes of the basal layer which 
divide and differentiate to form cells of the spinous, granular and cornified layers. The proliferating basal 
layer is a heterogeneous population comprising of epidermal stem cells and transit-amplifying cells which 
have limited self-renewal capacity and undergo differentiation after a few cycles (Watt, 1998). In the 
granular layer, keratinocytes begin to lose their organelles, express structural proteins characteristic for 
epidermal terminal differentiation, leading to the flattening, collapse and the eventual death of the cells. 
These flattened cells, corneocytes, which form the cornified layer, are rich in proteins and are embedded 
in a lipid matrix, giving the epidermis its water-retaining, chemical and mechanical properties, ensuring 
effective epidermal barrier function (Blank, 1953; Candi et al., 2005; Proksch et al., 2008).  
Autophagy is generally used to describe cellular processes leading to the degradation of cytoplasmic 
components within lysosomes (Levine and Klionsky, 2004; Shintani and Klionsky, 2004; Mizushima, 2007; 
Klionsky et al., 2016). Macroautophagy (commonly referred to as autophagy) is a conserved catabolic 
process characterized by formation of intracellular double-membrane structures which degrade and 
recycle cytosolic proteins and organelles (Arstila and Trump, 1968; Mizushima, 2007). Specialized forms 
of autophagy are directed at specific organelles such as mitophagy (mitochondria), nucleophagy (nuclei) 
(Klionsky et al., 2007; Cecconi and Levine, 2008; Levine and Kroemer, 2008; Park et al., 2009; Mizushima 
and Levine, 2010; McGee et al., 2011) and more recently ‘ER-phagy’ (endoplasmic reticulum) (Mochida et 
al., 2015; Khaminets et al., 2015). Autophagy in keratinocytes so far has been described as a mechanism 
of senescent cell death (Deruy et al., 2010, Gosselin et al., 2009), stress response leading to expression 
of early markers of differentiation and eventual cell death (Aymard et al., 2011), as well as a pro-survival 
mechanism which protects from UV-induced damage (Yang et al., 2012; Zhao et al., 2013; Qiang et al., 
2013). However most published work has been performed in monolayer keratinocyte culture which may 
not fully represents the stratified in vivo situation. A key regulator of epidermal development and 
differentiation is the AKT/mTOR pathway. Downstream of AKT is mTORC1 which regulates anabolic and 
catabolic processes including autophagy. Hyperactivation of mTORC1 signalling has been associated with 
a defective epidermal barrier in psoriasis (Kjellerup et al., 2009; Buerger et al., 2013) and vitamin D 
analogues used to treat epidermal barrier defect diseases such as psoriasis induce autophagy in cultured 
cells (Wang and Levine, 2011). Here we investigate the role of epidermal autophagy and its link epidermal 
terminal differentiation. 
 
RESULTS 
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Autophagy is involved in epidermal granular layer formation.  
During foetal development, expression studies are possible because of the temporal separation of 
epidermal terminal differentiation and skin barrier formation. We examined expression patterns of ULK1, 
BECN1, WIPI1, ATG5-ATG12 complex and LC3 as key markers of sequential stages of autophagy in the 
mouse embryo (Fig. 1A). Epidermal barrier formation correlates with development of the cornified layer 
which occurs between E15.5 and E18.5 in mice 43. In E16.5 mouse foetal skin, filaggrin expression 
confirmed activation of terminal differentiation and granular layer formation. Filaggrin is also constitutively 
expressed in the granular layer of adult human skin (Fig. 1B and S1B), and is further increased in foetal 
granular layers at E17.5 and E18.5, when AKT1 is also expressed, indicating the presence of an intact 
granular layer. At E15.5, before granular layer development, the epidermis consists of proliferating basal 
and spinous layers (Fig S1A). At this time point, LC3 as well as other autophagy proteins are present at 
low levels (Fig.1A). Initiation of granular layer formation at E16.5 is accompanied by upregulation of LC3 
in the uppermost layers which correspond to the early granular layers. Levels of ULK1, WIPI1 and 
granular ATG5-ATG12 are also further increased at E16.5, accompanied by switching-on of BECN1 
expression in the basal and upper epidermal layers. This autophagy marker expression pattern is 
maintained until birth and persists in adult mouse and human skin (Fig. 1A). In summary, expression of 
autophagy markers is highly upregulated at E16.5 indicating that autophagy occurs during epidermal 
development and differentiation, and may contribute to granular layer formation. 
Detection of epidermal autophagic vesicles in newborn mouse epidermis 
We then aimed to establish the presence and localisation of autophagic vesicles in normal epidermis. For 
this purpose we used three-day-old mouse epidermis since this time point allows a short recovery period 
after birth to exclude artefacts due to neonatal starvation-induced autophagy (Kuma et al., 2004). We first 
characterized by immunofluorescence the expression of the main autophagic markers which reveal the 
same patterns described during mouse epidermal development as well as adult mouse and human skin 
(Fig.2A). By using transmission electron microscopy (TEM) we investigated the ultrastructure of the 
epidermal granular layer (Fig. 2B) and we identified autophagic vesicles in both transitional cells and the 
cornified envelope (Fig. 2C-D). Autophagic vesicles within the epidermal layers varied in shape (from 
rounded to oval-shaped) with cross-sections within the range of 300-500 nm. These data confirmed 
previous reports describing epidermal autophagosomes in cultured keratinocytes, and also reveal that the 
autophagy process is occurring continuously, even in newborn mouse skin, and not only during epidermal 
development. 
mTORC1 regulation of epidermal autophagy.  
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mTORC1 is a key regulator of autophagy in yeast and mammals (Blommaart et al., 1995; Noda and 
Ohsumi, 1998; Ravikumar et al., 2004). Under nutrient-rich conditions, mTORC1 activates anabolic 
processes such as protein synthesis and inhibits catabolic processes such as autophagy. In order to 
establish whether epidermal autophagy is also regulated by mTORC1 signalling, the effects of mTOR 
inhibitors rapamycin and torin1 were analysed using a well-established assay for in vitro skin 
differentiation (O'Shaughnessy et al., 2009). Mouse skin explants were harvested from E15.5 foetuses 
when the granular layer and stratum corneum are still absent (Fig. 1A and S1A). After 72h of drug 
treatment (corresponding to E18.5, the time point just before birth), inhibition of mTORC1 does not have a 
striking effect on filaggrin expression patterns or on epidermal granular layer formation (Fig 3A and S1C). 
S6 phosphorylation (S240/244), a down-stream target of mTORC1, is reduced in drug-treated explant 
epidermis (Fig. 3A) confirming effective mTORC1 inhibition. The autophagosome marker LC3 is mainly 
expressed in the granular layer of adult epidermis (Fig. 1A) as well as in vehicle-treated explants. 
mTORC1 inhibition strongly increases epidermal LC3 levels (Fig. 3A) and induces conversion of LC3I to 
LC3II (Fig. 3B), a measure of autophagic activity. The expression of WIPI1, present as puncta in the upper 
layers of vehicle-treated foetal explants, is upregulated (Fig. 3A) as is ULK1 expression. Basal-lower 
spinous layer expression levels of ATG5-ATG12 and BECN1 were also increased (Fig. S1D). Therefore, 
mTORC1 inhibition increases expression of essential autophagy proteins and up-regulates LC3 
processing in the granular layer, consistent with induction of autophagy in the upper epidermis. Treatment 
in the last 4 hours of mTORC1 inhibition with Bafilomycin A1 (BafA1) - which prevents fusion of lysosomes 
with autophagosomes (Bowman et al., 1988; Klionsky et al., 2008) - confirmed the integrity of the 
autophagic flux in the granular layers of these mouse skin explants (Fig. 3C). 
 
To further explore whether mTORC1 inhibition effectively up-regulates autophagy in human epidermis, 
primary monolayer keratinocyte cultures were treated with rapamycin in the presence and absence of 
BafA1. Treatment with BafA1 leads to LC3II accumulation mainly in rapamycin-treated cells (Fig. 3D and 
E), confirming inhibition of autophagic vesicle degradation. Increased LC3 expression upon Rapamycin 
combined with BafA1 (Fig. 3D), as well as up-regulation of LC3 turnover (Fig. 3E) was mainly evident in 
differentiated keratinocytes.  Rapamycin induces a significantly higher turnover of LC3I to LC3II in 
differentiated compared to undifferentiated keratinocytes. Rapamycin also strongly down-regulates S6 
phosphorylation confirming effective mTORC1 inhibition. These data are consistent with our observations 
in mouse foetal explant cultures as well as in organotypic models using rat epidermal keratinocytes (REK) 
(Fig. 3F and S2A) and reveal the integrity of the “epidermal” autophagic flux, but also how sensitivity of 
autophagy in keratinocytes could be influenced by differentiation status.  
Epidermal nucleophagy during keratinocyte terminal differentiation  
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Having established that keratinocytes from differentiated granular layers are capable of higher levels of 
autophagy compared to basal proliferating cells, the role of autophagy during epidermal terminal 
differentiation was further investigated. Immunofluorescence analysis of autophagy proteins showed 
perinuclear localization of LC3, p62 und ULK1 in differentiated keratinocytes (Fig. S2B). Detailed 
examination of cell morphology revealed irregular or misshaped nuclei in a significant proportion of 
differentiated keratinocytes whereas these were rare in undifferentiated cells (Fig. 4A). Regions of 
degraded nuclear material in differentiated keratinocytes are replaced by LC3 aggregates which are also 
positive for LAMP2, a lysosomal membrane protein (Fig. 4B and Fig. S3A-B) which labels lysosomes and 
autolysosomes just before autophagic degradation. DAPI staining is reduced in intensity but is present in 
these LAMP2/LC3 aggregates, suggestive of active degradation of DNA in these bodies (Fig S3B). The 
regions of missing nuclear material may therefore be sites of high autophagic activity, a process defined 
as nucleophagy. p62 acts as an adaptor, recognizing and binding both ubiquitinated autophagic cargo and 
LC3 within autophagosomal membranes, and is commonly used as a read-out for targeted autophagic 
degradation of ubiquitinated cargo (Pankiv et al., 2007, Lamark et al., 2009, Johansen and Lamark, 2011, 
Klionsky et al., 2012). In keratinocyte cultures, nucleophagic regions in the differentiated population are 
p62 positive (Fig.4C). However, most LC3 vesicles in undifferentiated keratinocytes are negative for p62 
indicating that basal autophagy in proliferating keratinocytes is not targeted. These data indicate that 
nucleophagy is a mechanism of targeted autophagic degradation of cargo by which terminally 
differentiating keratinocytes might degrade their nuclei.  
 
To confirm whether these autophagic vesicles contain nuclear material, nucleophagic keratinocytes were 
analysed for expression of a histone interacting protein, Heterochromatin Protein 1α (HP1α), a marker of 
genetically inactive, tightly packed DNA found at the periphery of the nucleus (Maison and Almouzni, 
2004). HP1α is mainly expressed in nuclei of undifferentiated keratinocytes (Fig.4D). However, in 
differentiated keratinocytes, HP1α is present in both the nucleus and cytoplasm where it forms perinuclear 
aggregates in regions of missing nuclear material and overlaps with LAMP2. This observation suggests 
that nucleophagic vesicles contain nuclear material.  
To determine whether nucleophagic vesicles are in contact or coincident with the nucleus, the expression 
pattern of the nuclear membrane proteins lamin A (LMNA) and lamin B1 (LMNB1) was examined. Lamins 
are inner nuclear membrane proteins required for the maintenance of nuclear integrity (Hutchison, 2002; 
Broers et al., 2006). In both undifferentiated and differentiated keratinocytes, LMNA and LMNB1 are 
expressed at the nuclear membrane. Differentiating keratinocytes display an accumulation of LMNA and 
LMNB1 at the border between the existing nucleus and the autophagic regions (Fig. 4E-F). This shows 
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that LAMP2 positive autophagic vesicles at nucleophagic sites are cytosolic (4F) and also confirmed the 
involvement of Lamins in epidermal autophagic nuclear degradation (Dou Z et al., 2015). 
However in differentiated keratinocytes, acetylated histone H3 (Lys14) is only expressed within the intact 
nuclei and absent in nucleophagic regions (Fig. S3C). Thus, nucleophagy in keratinocytes is a targeted 
process whereby nuclear material within the nucleophagic regions differs from that within the intact 
nucleus where gene transcription may still occur. Nucleophagy is not a DNA damage response, as shown 
by lack of phosphorylated H2AX within nucleophagic regions (Fig. S3D). Moreover no caspase-3 cleavage 
(Fig. S4A) nor Tunel staining (unshown data) were detected within nucleophagic regions confirming no 
apoptotic response is triggered during nucleophagy.  
In order to establish whether autophagy is essential for degradation of nuclei during keratinocyte 
differentiation, a knockdown of key autophagy proteins WIPI1 and ULK1 was performed. WIPI1 interacts 
with autophagic structures under conditions of starvation or mTORC1 inhibition and physiologically 
colocalises with LC3 positive puncta; its expression is associated with terminal differentiation, both in 
culture and in the epidermis (Fig. S4B). WIPI1 knockdown significantly reduced nucleophagic cells in 
differentiating keratinocytes (~2%) compared to controls (~15%) whereas undifferentiated keratinocytes 
were unaffected (Fig.4G). Likewise, knockdown of, ULK1, another protein essential for autophagy, also 
reduced the number of nucleophagic differentiated keratinocytes, although to a lesser extent than with 
WIPI1 silencing (Fig. S4C), reinforcing the importance of the integrity of the autophagy pathway for 
nucleophagy in differentiating keratinocytes. Finally, we analyzed newborn mouse and adult human skin in 
order to validate the above observation in keratinocytes and confirm whether the nucleophagy process 
also occurs in epidermal models. By performing confocal microscopy analysis at higher magnification of 
LC3 expression within the granular layer of mice newborn skin we clearly observed that some of the LC3 
puncta in the granular layer were coincident with areas of loss of nuclear material, strongly suggesting an 
active nucleophagy process ongoing within the granular layer (Fig. 5A). Likewise, in upper layers of adult 
human skin, LC3 puncta were localized to the same regions of misshapen nuclei (Fig. 5B). By further 
analysing the granular layer ultrastructure of newborn mice skin with electron microscopy we also 
identified double-membrane vesicles containing heterochromatin material corresponding to perinuclear 
regions where nuclear material was lost (Fig. 5C-D). These data provide evidence of an epidermal 
autophagy process targeting nuclear integrity within the terminally differentiated layers of the skin. 
Deregulation of granular layer autophagy in psoriatic skin lesions.  
Psoriasis is a skin barrier defect characterized by epidermal hyperplasia, abnormal terminal differentiation 
of keratinocytes, infiltration of immune cells into the dermis and epidermis and increased vascularisation 
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(Raychaudhuri, 2012). Lesional psoriatic skin has a hyperproliferative, thickened epidermis, elongated 
rete ridges and a thicker cornified layer with retained nuclei or parakeratosis (Fig. 5A-B) (Wolberink et al., 
2011; Donetti et al., 2012; Kim et al., 2011), suggesting incomplete terminal differentiation. However, 
uninvolved skin in psoriasis has a clearly defined granular layer and corneocytes similar to healthy 
epidermis. To further investigate our hypothesis that autophagy is a mechanism for organelle degradation 
during terminal differentiation in epidermis, the expression pattern of several autophagy markers were 
analysed in skin from 6 patients with psoriasis and compared with several samples from healthy skin. In 
healthy adult epidermis, LC3 is expressed in all layers of the epidermis with the strongest expression in 
the granular layer (Fig. 1A; Fig. 5B). In psoriatic lesions, LC3 is completely absent from all layers of the 
epidermis (Fig. 5B). In non-lesional psoriatic epidermis where cornification occurs, LC3 is present in the 
granular layer, but its expression is reduced. Therefore in non-lesional psoriatic skin, where keratinocyte 
terminal differentiation and cornification are intact, granular layer LC3 is present but at lower levels 
compared to healthy epidermis. In psoriatic lesions where terminal differentiation is impaired leading to 
nuclear retention and improper cornification, LC3 is absent. WIPI1 is only expressed in the upper layers 
where cornification can occur, as in non-lesional psoriatic skin and in healthy skin. Its expression is 
reduced (like LC3), in parakeratotic regions of psoriatic epidermis. ULK1 is expressed in all layers of 
healthy epidermis with highest expression in the upper layers (Fig. 5B). Its expression significantly 
increases in supra-basal and granular layers of non-lesional psoriatic epidermis, whereas in lesional 
psoriatic epidermis, ULK1 is highly expressed everywhere except in the uppermost parakeratotic layers. 
Likewise BECN1, mainly expressed in the proliferating basal layer of healthy epidermis, shifts to basal and 
para-basal layers of non-lesional psoriatic epidermis, and supra-basal layers of lesional psoriatic skin (Fig. 
5B). ATG5-ATG12 is similar to BECN1 with a strong basal layer expression in healthy epidermis and no 
changes in non-lesional psoriatic skin, whereas a shift into supra-basal layers is observed in lesional 
psoriatic epidermis. This data shows deregulation of autophagy markers in both lesional and non-lesional 
psoriatic epidermis, providing a possible reason for the defective epidermal barrier observed in this 
disease.  
 
DISCUSSION 
In this report we demonstrate that autophagy is an active process playing a critical role in normal 
epidermal development and differentiation and that impaired autophagy may contribute to the 
pathogenesis of human disorders of epidermal differentiation such as psoriasis. 
An increasing number of publications has shown that keratinocytes are capable of autophagy (Gosselin et 
al., 2009; Aymard et al., 2011; Deruy et al., 2010; Lee et al., 2011; Chatterjea et al., 2011; Wang and 
Levine, 2011; Misovic et al., 2013). Most of these reports have used monolayer keratinocyte culture as a 
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research model, although this does not accurately represent late terminal differentiation in vivo. To date, 
an accurate profile of autophagy marker expression in healthy epidermis has not been established. The 
epidermal autophagy marker expression pattern suggests that autophagy plays an important role in the 
terminal differentiation process of the granular layer. We have recently identified a mechanism modulating 
the autophagy process in keratinocytes mediated by iASPP (Chikh et al., 2014), whose expression is also 
important for the maintenance of epidermal homeostasis (Chikh et al., 2011). Decreased iASPP 
expression in keratinocytes not only triggers autophagy by derepression of the ATG5/ATG12–ATG16L1 
complex, promoting autophagosome maturation, but also induces terminal differentiation. Likewise, 
another elegant study has recently highlighted the importance of BNIP3 in inducing autophagy but also 
terminal differentiation of epidermal keratinocytes (Moriyama et al., 2014). 
Here we have shown that induction of autophagy marker expression during foetal development coincides 
with the initiation of epidermal terminal differentiation. This suggests that autophagy is constitutively active 
in granular layer keratinocytes and may be important for granular layer formation. TEM analysis of 3-day-
old mouse epidermis shows that double-membrane vesicles containing engulfed material are present in 
basal and granular layers. Another report has recently shown autophagosome-like structures in granular 
layer of mouse skin (Soma-Nagae et al., 2013). Autophagy is regulated by different cell signaling 
pathways of which mTORC1 is a central player. In epidermis, the AKT/mTORC1 pathway is a key 
regulator of epidermal development and differentiation (Calautti et al., 2005; Thrash et al., 2006; 
O'Shaughnessy et al., 2007; Naeem et al., 2015) and we have previously shown that mTORC1 inhibition 
upregulates activity of epidermal AKT1, the AKT isoform associated with terminal differentiation (Sully et 
al., 2013). We were therefore interested to determine whether epidermal autophagy is also regulated by 
mTORC1. We observed that mTORC1 inhibition in epidermal explant cultures significantly increased the 
expression levels of most of the autophagy markers. These data support observations made in monolayer 
cultures where mTORC1 inhibition induces a striking increase in LC3 turn-over in differentiated 
keratinocytes. Moreover, increased expression of lipidated LC3 was also detected upon block of the 
autophagic flux, confirming integrity of the autophagy process in epidermal keratinocytes. Our findings 
strongly suggest that epidermal mTORC1 not only mediates AKT1 activity but also regulates constitutive 
granular layer autophagy. Interestingly, not all the autophagic markers localized within the granular 
epidermal layers. It is currently unclear whether inter-dependency exists between basal (BECN1, ATG5-
ATG12) epidermal layer autophagy markers and upper layer epidermal markers, or whether different 
streams of epidermal autophagy occur within the skin. Future experiments would elucidate the role of 
BECN1 and ATG5-ATG12 in the epidermal basal layer and may explore the function of basal layer 
epidermal autophagy.  
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Analysis of autophagy in monolayer cultures revealed that differentiating keratinocytes undergo 
nucleophagy - autophagic degradation of the nucleus. This differs from micro-nucleophagy in which 
satellite nuclei are formed due to stress or genome instability and then engulfed by autophagosomes 
(Krick et al., 2008; Rello-Varona et al., 2012). Recently a novel mechanism of nucleophagy mediated by 
Atg39, a nuclear envelope receptors which induces autophagic sequestration of part of the nucleus, has 
been identified in Saccharomyces cerevisiae (Mochida et al., 2015). Although we cannot exclude at this 
stage whether Atg39 could also be involved in our proposed mechanism, in differentiating keratinocytes 
nucleophagy is characterized by accumulation of LC3/LAMP2/p62 positive autolysosomes also containing 
HP1α positive cargo in the regions of missing nuclear material, suggesting selective autophagic 
degradation is occurring. Lack of DAPI detection within the nucleophagic regions might be due to 
chromatin conformational changes or partial degradation of the DNA leading to reduced DAPI 
incorporation into DNA. Our data suggest that nuclear material within the autophagosome may be 
damaged or modified and bound to HP1α, which is targeted for autophagic degradation. However, the 
material within the nucleophagic vesicles is not positive for the marker of DNA double-strand breaks, γ-
H2AX, nor for cleaved Caspase-3, suggesting nucleophagy degradation does not trigger an apoptotic 
response. A similar type of nucleophagy has recently been described in the aging intestinal epithelia of C. 
elegans, probably due to aging-related changes in LMNA, and compromised nuclear integrity (McGee et 
al., 2011). In our monolayer keratinocyte cultures nucleophagic vesicles are outside the partially degraded 
nucleus. Another model has just been reported in human primary fibroblasts also based on nuclear LC3 
directly interacting with LMNB1. Lamin B1 lysosomal degradation would rely on LC3–LMNB1 interaction 
as a general mechanism to protect the cells from oncogene-induced senescence and tumorigenesis (Dou 
Z et al., 2015). Lamin B1 is phosphorylated by AKT1 in the granular layer of the epidermis targeting it for 
degradation (Naeem et al., 2015). These two models of nucleophagy resemble our data in differentiating 
keratinocytes where we observe A and B1 Lamins accumulation exactly corresponding to regions of 
nuclear degradation. The rarity of nucleophagic events in vitro and in vivo suggests a rapid process which 
is dependent on the differentiating stage of keratinocytes. Finally we reinforced the importance of the 
integrity of the epidermal autophagy confirmed by lack of nucleophagy in differentiating keratinocytes 
depleted from key autophagy proteins WIPI1 or ULK1. 
A report recently showed that epidermal ATG7 knock-out mice have no skin phenotype suggesting that 
autophagy in the epidermis does not require ATG7 (Rossiter et al., 2013). Our observations of strong 
basal layer expression of BECN1 and ATG5-ATG12 suggest that these proteins may also play other roles 
in epidermis. It is likely that the precise mechanism of autophagy in epidermis may differ depending on the 
stage of keratinocyte differentiation and may also vary between mice and humans. It is noteworthy 
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mentioning that although no cornification defects were revealed by ultrastructural analysis, an increase in 
corneocyte thickness was identified in the back skin where Atg7 was specifically inactivated (Rossiter et 
al., 2013). Another group has recently grafted Atg7-deficient skin onto severe combined immunodeficient 
mice and observed acanthosis, hyperkeratosis, abnormal hair growth and an overall retardation of 
granular layer differentiation in the autophagy-deficient grafts(Yoshihara et al., 2015). Further investigation 
will determine and validate alternative Atg5/Atg7-independent autophagy pathways (Nishida et al., 2009) 
in human epidermis. 
Psoriasis was used as a human disease model to validate our hypothesis and observations. Psoriasis is 
characterized by keratinocyte hyperproliferation, deregulated terminal differentiation and parakeratosis, 
inflammation and abnormal vascularisation, resulting in the defective epidermal barrier present in psoriatic 
plaques (Griffiths and Barker, 2007; Raychaudhuri, 2013). We show that LC3 puncta were still present in 
the granular layer of non-lesional psoriatic epidermis but at a much lower level compared to healthy adult 
epidermis, whereas in lesional psoriatic skin, LC3 was not expressed at all. Likewise, no expression of 
ULK1 or WIP1 was detected in the parakeratotic regions of psoriatic skin, whereas a shift of BECN1 and 
ATG5-ATG12 expression was observed in psoriatic lesions. Therefore, the overall autophagy expression 
marker profile does only apply to an epidermal model capable of complete terminal differentiation. 
Moreover, hyperactivation of mTORC1 has been shown in lesional psoriatic skin (Kjellerup et al., 2009; 
Buerger et al., 2013). High mTORC1 signalling would inhibit autophagy and may explain why LC3 
aggregates formation is absent in psoriatic lesions. Previous reports have shown that activation of Toll-
Like-Receptor (TLR) signalling in keratinocytes causes hyperproliferation and inflammation and induces 
p62 expression which further increases TLR signalling. However, in healthy keratinocytes, autophagy 
keeps epidermal p62 levels in check thereby preventing epidermal inflammation (Lee et al., 2011; Miller, 
2008). The absent or reduced LC3, ULK1, WIP1 expression levels in psoriatic skin suggest that 
autophagy may be blocked or impaired, explaining the high p62 levels and contributing to excessive 
inflammation (Lee et al., 2011). These data suggest that patients with epidermal barrier defect diseases 
such as psoriasis may benefit from treatment with mTORC1 inhibitors. Such an approach could restore 
constitutive epidermal granular layer autophagy which may lead to normalisation of terminal differentiation 
and barrier formation, and possibly reduce inflammation and hyperproliferation.  
In conclusion, our data reveal the extent and location of autophagy in epidermal development and 
differentiation and highlight its critical importance in ensuring normal epidermal function and its potential 
role in disease of epidermal barrier function. 
MATERIALS AND METHODS 
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Cultures of primary keratinocytes and skin explants. Human neonatal primary keratinocytes 
purchased from Invitrogen were expanded in Medium 154 (Invitrogen) with 0.2 mM Calcium chloride on 
collagen-coated plates (rat-tail collagen, BD Biosciences). More details of this technique are included in 
the Suppl. Materials and Methods 
 
Immunohistochemistry. Tissue specimens were fixed in Bouin’s solution and embedded in paraffin. 
More details of this technique and a list of the antibodies used are included in the Suppl. Materials and 
Methods.  
 
Transmission Electron Microscopy. The processing, embedding, cutting and imaging of the TEM 
sections were performed by the Pathology Core Facility of Queen Mary University of London. 3 day old 
dorsal mouse skin from CD1 mice was harvested and cut into strips of 1 mm width. The strips were fixed 
in 4% Glutaraldehyde in 0.1 M phosphate buffer (3.1 g Sodium phosphate monobasic monohydrate, 10.9 
g Sodium phosphate dibasic (pH 7.4) per L) and embedded in LR White. 
More Experimental procedures are described in Suppl. Materials and Methods. 
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FIGURE LEGENDS 
Figure 1: Induction of epidermal terminal differentiation during foetal development is accompanied by 
activation of autophagy marker expression. A) Expression of AKT1, epidermal terminal differentiation 
marker, filaggrin and autophagy proteins LC3, ULK1, WIPI1, BECN1 and ATG5-ATG12 in mouse foetal 
skin development. Epidermal expression levels of LC3, ULK1 and WIPI1 were quantified in n= 3 foetal 
mouse samples from E15.5 to E18.5. ANOVA for average intensities from n=3 samples of epidermal LC3 
(p<0.00005), ULK1 (p<0.0005), WIPI1 (p<0.005) respectively. B). Expression of epidermal terminal 
differentiation and autophagy markers in both adult mouse and adult human epidermis. Bar = 20µm. 
Dotted line = basement membrane.  
Figure 2: Epidermal autophagic vesicles in epidermal layers of newborn mice skin. A) Immunofluorescent 
analysis of d3 mouse back skin for the key autophagic markers LC3, ULK1, ATG5-ATG12 and BECN1. B) 
Transmission electron microscopy analysis (TEM) of the granular layer of the epidermis shows degrading 
nuclei (N). The cornified layer in this image is to the right. C) Double membrane-autophagic vesicles are 
present in the granular layer keratinocytes. D) Autophagic vesicles are present in the cornified layer of the 
epidermis. E) Another image of a double membrane putative autophagic vesicle in the basal layer of the 
epidermis. Dotted line (A) indicates the dermal-epidermal boundary. Bars = 50µm (A), 2µm (B), 500nm 
(C), 200nm (D and E). 
Figure 3: mTOR inhibition up-regulates constitutive autophagy in terminally differentiating keratinocytes. 
A) Expression of epidermal S6 phosphorylation, terminal differentiation and autophagy markers in mouse 
foetal explants isolated at E15.5 and treated with vehicle, 2.5 µM Torin1 or 5 µM rapamycin for 72h. *= 
Two tailed paired t-test (P<0.05) quantified for 4 different fields of view. B) Western blots analysis of the 
above (A) treated explant cultures. C) Western blots analysis showing autophagic flux of Torin1 (2.5µM for 
72h) treated epidermal explant w/o 100 nM BafA1 (in the last 4h). D) Immunofluorescence LC3 staining of 
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differentiated primary keratinocytes treated with 10nM rapamycin w/o 100 nM BafA1. E) Measurement of 
autophagic flux by Western blots analysis of rapamycin treated human primary keratinocytes w/o 100 nM 
BafA1. Actin was used as a loading control. *= Two tailed paired t-test (P<0.05) for LC3II/LC3I ratios in 
differentiated keratinocytes. F) Measurement of autophagic flux by Western blots analysis of 10nM 
rapamycin treated REK w/o 200 µM Chloroquine. Bar = 20µm. Dotted line = basement membrane.  
Figure 4: Terminal differentiation in monolayer keratinocyte cultures is accompanied by targeted 
autophagic degradation of nuclear material – nucleophagy. A) DAPI staining analysis reveals presence of 
misshaped nuclei (red arrows) within differentiated keratinocytes. Statistical significance (*P<0.05) was 
measured by Two tailed paired t-test. Immunofluorescence staining reveals B) co-expression of 
LC3/LAMP2; C) co-expression of LC3/p62 (D) co-expression HP1α/LAMP2 specifically within regions of 
missing nuclear material of primary differentiated keratinocyte cultures. Red arrows indicate HP1α 
aggregates. (E) LMNA labelling reveals that nuclear membrane is still present between nucleus and 
nucleophagic regions. F) Detailed investigation of LMNB1 and LAMP2 expression in calcium-switched 
human keratinocytes. Pre, indicates early events whereby a small amount of nuclear material is exposed. 
Early, indicates a time-point where co-expression of LAMP2, LMNB1 and DAPI is occurring. Mid, indicates 
a time-point where DAPI and LMNB1 expression is lost within LAMP2 positive bodies. Late, indicates 
misshaped nuclei in the absence of LAMP2 positive bodies (like in A). G) Western blots analysis of WIPI1 
siRNA silencing in keratinocytes. *=Two tailed paired t-test (P<0.05). Bar = 10µm. Small red arrows = 
regions of nuclear deformity (A) and (E) or regions of peri-nuclear protein accumulation (D). 
Figure 5: Figure 5: Nucleophagy in terminal differentiated layers of mouse and human epidermis. A) 
Confocal microscopy of LC3 expression in d3 postnatal back skin. Left panel: low magnification of multiple 
LC3 positive nuclei. Right panel: optical section demonstrates LC3 bodies through nuclear invaginations 
(magnification 0.5 micron). Bar graph shows percentage of nuclei co-localizing in the granular layer and 
the rest of the epidermis. B) LC3 accumulation within the granular layer of adult human trunk skin. Insets 
show 0.5 micron optical sections through one of the nuclei undergoing nucleophagy, with LC3 puncta in 
an invagination of the nucleus. Bar graph shows percentage of nuclei co-localizing in the granular layer 
and the rest of the epidermis. C) and D), TEM images of nuclei in the granular layer of d3 postnatal back 
skin. Arrowheads point to putative double membrane nucleophagic bodies associated with degrading 
nuclei. M, mitochondrion, N, Nucleus. **, p<0.001, Fishers exact test (n=81 mouse, n=419 human). Bars 
50µm (A and B, low mag) 10 µm (A and B, High mag). Dotted line (A) indicates the dermal-epidermal 
boundary. 
Figure 6: Constitutive granular layer autophagy is deregulated in psoriasis, an epidermal barrier defect 
disease. (A) H&E staining of psoriatic lesion, non-lesional psoriasis and healthy epidermis showing thicker 
uppermost layer and nuclei retention in psoriatic lesion (blue vertical line), whereas cornified layer of non-
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lesional psoriatic skin and healthy epidermis are completely free from nuclei (blue vertical line). In psoriatic 
lesions, there is no clear granular layer compared to non-lesional psoriatic skin and healthy epidermis 
(blue arrows). Black bar = 20 µm. (B) Immunofluorescence analysis of autophagy markers on lesional 
psoriatic skin compared to non-lesional psoriatic and healthy epidermis. Red vertical bars = cornified 
layers. Black bar = 20µm. This figure is representative of n=6 samples of psoriatic lesions and n=5 
samples of healthy epidermis.   
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